Theraclone raises $14M to ID rare human antibodies that could be used to fight disease Seattle biotechnology company Theraclone Sciences has raised an additional $8 million in equity financing and $6 million in debt, bringing… Read More
Tech Moves: Mobilisafe adds marketing VP; Theraclone names CEO; BigDoor; etc. Sajal Sahay has joined Seattle mobile security upstart Mobilisafe as vice president of marketing with the goal of helping to… Read More
Theraclone Sciences raises $10M Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors… Read More
